Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

NASDAQ:GLRE - Nasdaq - KYG4095J1094 - Common Stock - Currency: USD

13.95  +0.12 (+0.87%)

After market: 13.95 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GLRE. GLRE was compared to 144 industry peers in the Insurance industry. GLRE has an average financial health and profitability rating. GLRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year GLRE was profitable.
In the past year GLRE had a positive cash flow from operations.
GLRE had positive earnings in 4 of the past 5 years.
In multiple years GLRE reported negative operating cash flow during the last 5 years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

GLRE's Return On Assets of 4.39% is amongst the best of the industry. GLRE outperforms 80.42% of its industry peers.
With a Return On Equity value of 13.24%, GLRE perfoms like the industry average, outperforming 56.64% of the companies in the same industry.
Industry RankSector Rank
ROA 4.39%
ROE 13.24%
ROIC N/A
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 13.31%, GLRE is in the better half of the industry, outperforming 73.43% of the companies in the same industry.
GLRE's Profit Margin has improved in the last couple of years.
GLRE has a Operating Margin of 9.03%. This is comparable to the rest of the industry: GLRE outperforms 41.26% of its industry peers.
GLRE's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.03%
PM (TTM) 13.31%
GM N/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GLRE has been increased compared to 1 year ago.
The number of shares outstanding for GLRE has been reduced compared to 5 years ago.
GLRE has a better debt/assets ratio than last year.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

GLRE has a debt to FCF ratio of 0.60. This is a very positive value and a sign of high solvency as it would only need 0.60 years to pay back of all of its debts.
GLRE has a better Debt to FCF ratio (0.60) than 76.22% of its industry peers.
GLRE has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
GLRE has a Debt to Equity ratio of 0.09. This is amongst the best in the industry. GLRE outperforms 81.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.6
Altman-Z N/A
ROIC/WACCN/A
WACC8.45%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GLRE have decreased by -9.68% in the last year.
GLRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 151.28% yearly.
GLRE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.33%.
Measured over the past years, GLRE shows a very strong growth in Revenue. The Revenue has been growing by 30.32% on average per year.
EPS 1Y (TTM)-9.68%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%158.97%
Revenue 1Y (TTM)6.33%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%5.1%

3.2 Future

The Earnings Per Share is expected to decrease by -11.82% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-14.29%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6 -8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

GLRE is valuated cheaply with a Price/Earnings ratio of 5.54.
GLRE's Price/Earnings ratio is rather cheap when compared to the industry. GLRE is cheaper than 81.82% of the companies in the same industry.
GLRE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
GLRE is valuated reasonably with a Price/Forward Earnings ratio of 8.55.
69.93% of the companies in the same industry are more expensive than GLRE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. GLRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.54
Fwd PE 8.55
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

62.24% of the companies in the same industry are more expensive than GLRE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GLRE is valued a bit cheaper than 69.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.67
EV/EBITDA 8.28
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as GLRE's earnings are expected to decrease with -11.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%

More info and screens

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (3/7/2025, 8:00:01 PM)

After market: 13.95 0 (0%)

13.95

+0.12 (+0.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)03-10 2025-03-10/amc
Inst Owners50.48%
Inst Owner Change3.87%
Ins Owners23.98%
Ins Owner Change-0.1%
Market Cap485.88M
Analysts43.33
Price TargetN/A
Short Float %0.63%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.27%
Min EPS beat(2)-9.8%
Max EPS beat(2)52.34%
EPS beat(4)2
Avg EPS beat(4)13.71%
Min EPS beat(4)-9.8%
Max EPS beat(4)52.34%
EPS beat(8)6
Avg EPS beat(8)75.52%
EPS beat(12)6
Avg EPS beat(12)-66.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)-103.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.54
Fwd PE 8.55
P/S 0.74
P/FCF 4.67
P/OCF 4.67
P/B 0.73
P/tB 0.73
EV/EBITDA 8.28
EPS(TTM)2.52
EY18.06%
EPS(NY)1.63
Fwd EY11.7%
FCF(TTM)2.99
FCFY21.43%
OCF(TTM)2.99
OCFY21.43%
SpS18.94
BVpS19.05
TBVpS19.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 13.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.03%
PM (TTM) 13.31%
GM N/A
FCFM 15.78%
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.6
Debt/EBITDA 1.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.63
Cash Conversion 174.64%
Profit Quality 118.52%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%158.97%
EPS Next Y-14.29%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)6.33%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%5.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.55%
EBIT growth 3Y98.58%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y260.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y260.31%
OCF growth 3YN/A
OCF growth 5YN/A